Education
About Us
Working with TipRanks
Follow Us
Astrazeneca Plc (AZN)
NASDAQ:AZN
Total Valuation
AstraZeneca has a market cap or net worth of $215.83B. The enterprise value is $229.41B.
Market Cap$215.83B
Enterprise Value$229.41B
Share Statistics
AstraZeneca has 3.10B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3.10B
Owened by Insiders
Owened by Instutions6.34%
Financial Efficiency
AstraZeneca’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 10.30%.
Return on Equity (ROE)17.25%
Return on Assets (ROA)6.76%
Return on Invested Capital (ROIC)10.30%
Return on Capital Employed (ROCE)13.13%
Revenue Per Employee$573,414.634
Profits Per Employee$74,602.333
Employee Count94,300
Asset Turnover0.52
Inventory Turnover1.93
Valuation Ratios
The current PE Ratio of AstraZeneca is 28.95. AstraZeneca’s PEG ratio is 1.53.
PE Ratio28.95
PS Ratio3.77
PB Ratio4.99
Price to Fair Value4.99
Price to FCF27.99
Price to Operating Cash Flow17.17
PEG Ratio1.53
Income Statement
In the last 12 months, AstraZeneca had revenue of $54.07B and earned $7.04B in profits. Earnings per share was $4.54.
Revenue$54.07B
Gross Profit$43.87B
Operating Income$10.00B
Pretax Income$8.69B
Net Income$7.04B
EBITDA17.22B
Earnings Per Share (EPS)4.54
Cash Flow
In the last 12 months, operating cash flow was $11.86B and capital expenditures -$4.59B, giving a free cash flow of $7.28B billion.
Operating Cash Flow$11.86B
Free Cash Flow$7.28B
Free Cash Flow per Share$2.35
Dividends & Yields
AstraZeneca pays an annual dividend of $1.03, resulting in a dividend yield of 2.22%
Dividend Per Share$1.03
Dividend Yield2.22%
Payout Ratio37.00%
Free Cash Flow Yield7.14%
Earnings Yield3.45%
Stock Price Statistics
Beta0.42
52-Week Price Change3.16%
50-Day Moving Average73.49
200-Day Moving Average73.56
Relative Strength Index (RSI)40.91
Average Volume (3m)5.95M
Important Dates
AstraZeneca upcoming earnings date is Apr 29, 2025, Before Open.
Last Earnings DateFeb 6, 2025
Next Earnings DateApr 29, 2025
Ex-Dividend DateFeb 21, 2025
Financial Position
AstraZeneca as a current ratio of 0.93, with Debt / Equity ratio of 0.74
Current Ratio0.93
Quick Ratio0.74
Debt to Market Cap0.14
Net Debt to EBITDA1.44
Interest Coverage Ratio5.74
Taxes
In the past 12 months, AstraZeneca has paid $1.65B in taxes.
Income Tax$1.65B
Effective Tax Rate18.99%
Enterprise Valuation
AstraZeneca EV to EBITDA ratio is 7.39, with an EV/FCF ratio of 17.38.
EV to Sales2.34
EV to EBITDA7.39
EV to Free Cash Flow17.38
EV to Operating Cash Flow10.66
Balance Sheet
AstraZeneca has $5.65B in cash and marketable securities with $30.11B in debt, giving a net cash position of $24.46B billion.
Cash & Marketable Securities$5.65B
Total Debt$30.11B
Net Cash$24.46B
Net Cash Per Share$7.89
Tangible Book Value Per Share-$11.15
Margins
Gross margin is 81.12%, with operating margin of 18.50%, and net profit margin of 13.01%.
Gross Margin81.12%
Operating Margin18.50%
Pretax Margin16.07%
Net Profit Margin13.01%
EBITDA Margin31.66%
EBIT Margin19.29%
Analyst Forecast
The average price target for AstraZeneca is $93.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$93.18
Price Target Upside36.11%
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast18.03%
EPS Growth Forecast18.11%